It seems that a direct association exists between COVID-19 and blood hypercoagulability, since elevated levels of D-dimers and fibrin degradation products, as well as prolongation of prothrombin time, have been documented in severe forms of COVID-19 and are significantly associated with increased mortality [1,7,8,9,10,11]. The gene discussed is F2; the disease is COVID-19.